772 related articles for article (PubMed ID: 15700617)
1. Predictive value of primate models for AIDS.
Haigwood NL
AIDS Rev; 2004; 6(4):187-98. PubMed ID: 15700617
[TBL] [Abstract][Full Text] [Related]
2. Antiretroviral drug studies in nonhuman primates: a valid animal model for innovative drug efficacy and pathogenesis experiments.
Van Rompay KK
AIDS Rev; 2005; 7(2):67-83. PubMed ID: 16092501
[TBL] [Abstract][Full Text] [Related]
3. The role of nonhuman primates in the development of an AIDS vaccine.
Nathanson N; Hirsch VM; Mathieson BJ
AIDS; 1999; 13 Suppl A():S113-20. PubMed ID: 10885770
[TBL] [Abstract][Full Text] [Related]
4. Nonhuman primate models for HIV vaccine development.
Letvin NL
Immunodefic Rev; 1992; 3(3):247-60. PubMed ID: 1510838
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of antiretrovirals in animal models of HIV infection.
Van Rompay KK
Antiviral Res; 2010 Jan; 85(1):159-75. PubMed ID: 19622373
[TBL] [Abstract][Full Text] [Related]
6. [Novel vaccines against M. tuberculosis].
Okada M
Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
[TBL] [Abstract][Full Text] [Related]
7. Candidate vaccines protect macaques against primate immunodeficiency viruses.
Stott J; Hu SL; Almond N
AIDS Res Hum Retroviruses; 1998 Oct; 14 Suppl 3():S265-70. PubMed ID: 9814954
[TBL] [Abstract][Full Text] [Related]
8. Worldwide survey of AIDS vaccine challenge studies in nonhuman primates: vaccines associated with active and passive immune protection from live virus challenge.
Warren JT; Dolatshahi M
J Med Primatol; 1992; 21(2-3):139-86. PubMed ID: 1433265
[TBL] [Abstract][Full Text] [Related]
9. HIV vaccine development: Lessons from the past, informing the future.
Bradac J; Dieffenbach CW
IDrugs; 2009 Jul; 12(7):435-9. PubMed ID: 19579164
[TBL] [Abstract][Full Text] [Related]
10. HIV vaccine development at the turn of the 21st century.
Girard MP; Plotkin SA
Curr Opin HIV AIDS; 2012 Jan; 7(1):4-9. PubMed ID: 22156840
[TBL] [Abstract][Full Text] [Related]
11. AIDS vaccine development in primate models.
Almond NM; Heeney JL
AIDS; 1998; 12 Suppl A():S133-40. PubMed ID: 9632994
[No Abstract] [Full Text] [Related]
12. Obstacles and progress toward development of a preventive HIV vaccine.
Heyward WL; MacQueen KM; Jaffe HW
J Int Assoc Physicians AIDS Care; 1997 Aug; 3(8):28-34. PubMed ID: 11364630
[TBL] [Abstract][Full Text] [Related]
13. 25 years of HIV research! ... and what about a vaccine?
Appay V
Eur J Immunol; 2009 Aug; 39(8):1999-2003. PubMed ID: 19672891
[TBL] [Abstract][Full Text] [Related]
14. MHC polymorphism: AIDS susceptibility in non-human primates.
Bontrop RE; Watkins DI
Trends Immunol; 2005 Apr; 26(4):227-33. PubMed ID: 15797514
[TBL] [Abstract][Full Text] [Related]
15. Encouraging vaccine results from primate models of HIV type 1 infection.
Schultz A
AIDS Res Hum Retroviruses; 1998 Oct; 14 Suppl 3():S261-3. PubMed ID: 9814953
[TBL] [Abstract][Full Text] [Related]
16. [Primates as a model for the study of lentiviruses and AIDS].
Dormont D
Pathol Biol (Paris); 1990 Mar; 38(3):182-8. PubMed ID: 2110647
[TBL] [Abstract][Full Text] [Related]
17. No vaccine against HIV yet--are we not perfectly equipped?
Singh M
Virol J; 2006 Aug; 3():60. PubMed ID: 16939652
[TBL] [Abstract][Full Text] [Related]
18. HIV vaccine development and evaluation: realistic expectations.
Heyward WL; MacQueen KM; Goldenthal KL
AIDS Res Hum Retroviruses; 1998 Oct; 14 Suppl 3():S205-10. PubMed ID: 9814945
[TBL] [Abstract][Full Text] [Related]
19. The use of nonhuman primate models of HIV infection for the evaluation of antiviral strategies.
Van Rompay KK
AIDS Res Hum Retroviruses; 2012 Jan; 28(1):16-35. PubMed ID: 21902451
[TBL] [Abstract][Full Text] [Related]
20. AIDS vaccine development: the long and winding road.
Garber DA; Feinberg MB
AIDS Rev; 2003; 5(3):131-9. PubMed ID: 14598562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
